Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial
Expanded access is no longer available for this treatment.
Study NCT00071708 Information provided by Eli Lilly and Company
First Received: October 29, 2003 Last Updated: July 30, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Major Depressive Disorder
Fibromyalgia
Generalized Anxiety Disorder
Additional conditions recognized in this trial
Anxiety Disorders
Depression
Depressive Disorder
Depressive Disorder, Major
Diabetic Neuropathies
Disease
Myofascial Pain Syndromes
More general conditions related to this trial
Behavioral Symptoms
Diabetes Complications
Diabetes Mellitus
Endocrine System Diseases
Mental Disorders
Mood Disorders
Muscular Diseases
Musculoskeletal Diseases
Nervous System Diseases
Neuromuscular Diseases
Pathologic Processes
Peripheral Nervous System Diseases
Rheumatic Diseases
Interventions listed in this trial
Duloxetine Hydrochloride
Additional drug interventions recognized in this trial
Duloxetine
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Uptake Inhibitors
Antidepressive Agents
Central Nervous System Agents
Dopamine Agents
Dopamine Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Eli Lilly and Company
Back to top of Main Content
